ProfileGDS4132 / 231350_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 37% 40% 28% 27% 37% 54% 29% 35% 26% 27% 32% 30% 30% 24% 35% 34% 30% 30% 29% 28% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10195.405637
GSM201543Muscle PCOS pioglitazone 12194.142340
GSM201544Muscle PCOS pioglitazone 16171.561828
GSM201545Muscle PCOS pioglitazone 20171.23227
GSM201829Muscle PCOS pioglitazone 23199.999537
GSM201830Muscle PCOS pioglitazon 251153.27854
GSM201831Muscle PCOS pioglitazone 27168.398129
GSM201832Muscle PCOS pioglitazone 3190.163235
GSM201833Muscle PCOS pioglitazone 4158.179426
GSM201834Muscle PCOS pioglitazone 8164.096427
GSM201835Muscle PCOS after pioglitazone 10265.466832
GSM201836Muscle PCOS after pioglitazone 12263.01630
GSM201837Muscle PCOS after pioglitazone 16259.408630
GSM201838Muscle PCOS after pioglitazone 20250.514924
GSM201839Muscle PCOS after pioglitazone 23280.183535
GSM201840Muscle PCOS after pioglitazone 25280.41634
GSM201841Muscle PCOS after pioglitazone 27261.243930
GSM201842Muscle PCOS after pioglitazone 3259.313130
GSM201843Muscle PCOS after pioglitazone 4268.198829
GSM201844Muscle PCOS after pioglitazone 8262.057128